O=C1C2C3C=CC([C@@H]2C(=O)N1C1CC1)[C@H]1C(=O)N(C2CC2)C(=O)C31
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?